Researchers have also explored DSIPs possible role in stress regulation, hormone signaling, and pain modulation, but the overall evidence remains preliminary and insufficient for definitive clinical recommendations
"Novo Nordisk says stopping obesity drug may cause full weight regain in 5 years"
For context, the interplay between hormones and peptide signaling during this transition is an active research area, including a peer-reviewed update in the National Library of Medicine examining estrogens and neuropeptides in postmenopausal women
Both contain the same active molecule
Some people may not have any adverse effects at all, while others deal with ongoing problems
In preclinical studies, BPC-157 has shown a favorable safety profile